Experts on the panel shared many of the same views around SSRIs, arguing that the risks of the drugs during pregnancy are greater than currently accepted.

There were warnings to the FDA about Sarepta Therapeutics Inc. before US regulators asked the company to halt shipments of its gene therapy.

Sarepta CEO Doug Ingram said it is important the company maintains a “positive working relationship” with the FDA.

Depo-Provera is a birth control shot that is injected every three months and features a type of progestin hormone called ...

As the Texas legislature convenes for a special session this week, members have so far introduced a number of bills that ...

The FDA asked Sarepta to pause all U.S. shipments of the DMD gene therapy Elevidys, and the company has agreed after initially refusing.

The FDA's assessment of the bread recall has designated it as a Class II risk, which means the product "may cause temporary ...

A nonprofit anti-vaccine group founded by Robert F. Kennedy Jr. is suing him, in his capacity as secretary of the US Department of Health and Human Services, for failing to establish a task force to ...